HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric S Schafer Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

10/2022Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001).
1/2022Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
12/2020A Case of a Very Young Child With T Lymphoblastic Lymphoma With Eosinophilia and PDGFRB Translocation: A Rare Form of Myeloid/Lymphoid Neoplasm Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB or FGFR1.
11/2020Hispanic ethnicity is associated with prolonged clearance of high dose methotrexate and severe nephrotoxicity in children and adolescents with acute lymphoblastic leukemia.
1/2020Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage.
1/2020Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL).
1/2019A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities.
2/2018Evaluation of aprepitant for acute chemotherapy-induced nausea and vomiting in children and adolescents with acute lymphoblastic leukemia receiving high-dose methotrexate.
12/2017Treatment-related sinusoidal obstruction syndrome in children with de novo acute lymphoblastic leukemia during intensification.
1/2017Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for Toxicity.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric S Schafer Research Topics

Disease

13Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2022 - 05/2011
6Neoplasms (Cancer)
10/2022 - 01/2018
4Leukemia
10/2022 - 01/2019
3Lymphoma (Lymphomas)
10/2022 - 01/2022
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2022 - 01/2016
2Ewing Sarcoma (Sarcoma, Ewing)
01/2020 - 01/2018
2Central Nervous System Neoplasms
01/2020 - 01/2018
1Mucositis
10/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022
1Tumor Lysis Syndrome
10/2022
1Hypokalemia
10/2022
1Febrile Neutropenia
10/2022
1Eosinophilia
12/2020
1Hypoglycemia (Reactive Hypoglycemia)
01/2019
1Nausea
02/2018
1Vomiting
02/2018
1Neutropenia
01/2018
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
12/2017
1Sinus Histiocytosis (Rosai-Dorfman Disease)
02/2016
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2016
1Cytopenia
02/2016
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2014

Drug/Important Bio-Agent (IBA)

5Methotrexate (Mexate)FDA LinkGeneric
11/2020 - 01/2017
3Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
01/2020 - 06/2014
3Allopurinol (Remid)FDA LinkGeneric
01/2020 - 06/2014
2DecitabineFDA Link
10/2022 - 01/2022
2VorinostatFDA Link
10/2022 - 01/2022
22-mercaptopurineIBA
01/2019 - 06/2014
2Thioguanine (Tioguanine)FDA Link
12/2017 - 06/2014
1fludarabineIBA
10/2022
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2022
1Etoposide (VP 16)FDA LinkGeneric
10/2022
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
10/2022
1TOR Serine-Threonine KinasesIBA
10/2022
1temsirolimusFDA Link
10/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022
1Alanine Transaminase (SGPT)IBA
10/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2022
1Bortezomib (Velcade)FDA Link
01/2022
1Proteasome InhibitorsIBA
01/2022
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
12/2020
1talazoparibIBA
01/2020
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2020
1Temozolomide (Temodar)FDA LinkGeneric
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1Aprepitant (Emend)FDA Link
02/2018
1eribulinFDA Link
01/2018
1Sirolimus (Rapamycin)FDA Link
02/2016
16-methylthiopurineIBA
06/2014
1Matrix Metalloproteinases (MMPs)IBA
06/2014
1NucleotidesIBA
06/2014

Therapy/Procedure

4Therapeutics
10/2022 - 05/2011
4Drug Therapy (Chemotherapy)
01/2022 - 02/2016
1Hematopoietic Stem Cell Transplantation
01/2016